Among 10,723 patients, 5-year AF recurrence was 41% with precipitant vs. 52% without (HR 0.75), indicating a lower risk in the precipitant group.
Does the presence of an acute precipitant affect the long-term recurrence of atrial fibrillation and associated morbidity and mortality in patients with newly diagnosed AF?
Atrial fibrillation occurring after an acute precipitant frequently recurs and is associated with substantial long-term morbidity and mortality, highlighting the need for ongoing surveillance rather than treating it as a benign, isolated event.
Absolute Event Rate: 0% vs 0%
Background: Atrial fibrillation (AF) may occur after an acute precipitant and subsequently resolve. Management guidelines for AF in these settings are unclear as the risk of recurrent AF and related morbidity is poorly understood. We examined the relations between acute precipitants of AF and long-term recurrence of AF in a clinical setting. Methods: From a multi-institutional longitudinal electronic medical record database, we identified patients with newly diagnosed AF between 2000 and 2014. We developed algorithms to identify acute AF precipitants (surgery, sepsis, pneumonia, pneumothorax, respiratory failure, myocardial infarction, thyrotoxicosis, alcohol, pericarditis, pulmonary embolism, and myocarditis). We assessed risks of AF recurrence in individuals with and without a precipitant and the relations between AF recurrence and heart failure, stroke, and mortality. Results: Among 10 723 patients with newly diagnosed AF (67.9±9.9 years, 41% women), 19% had an acute AF precipitant, the most common of which were cardiac surgery (22%), pneumonia (20%), and noncardiothoracic surgery (15%). The cumulative incidence of AF recurrence at 5 years was 41% among individuals with a precipitant compared with 52% in those without a precipitant (adjusted hazard ratio HR, 0.75 95% CI, 0.69–0.81; P <0.001). The lowest risk of recurrence among those with precipitants occurred with postoperative AF (5-year incidence 32% in cardiac surgery and 39% in noncardiothoracic surgery). Regardless of the presence of an initial precipitant, recurrent AF was associated with increased adjusted risks of heart failure (hazard ratio, 2.74 95% CI, 2.39–3.15; P <0.001), stroke (hazard ratio, 1.57 95% CI, 1.30–1.90; P <0.001), and mortality (hazard ratio, 2.96 95% CI, 2.70–3.24; P <0.001). Conclusions: AF after an acute precipitant frequently recurs, although the risk of recurrence is lower than among individuals without an acute precipitant. Recurrence is associated with substantial long-term morbidity and mortality. Future studies should address surveillance and management after newly diagnosed AF in the setting of an acute precipitant.
Wang et al. (Wed,) reported a other. Among 10,723 patients, 5-year AF recurrence was 41% with precipitant vs. 52% without (HR 0.75), indicating a lower risk in the precipitant group.